和黄医药：执行董事兼首席财务官郑泽锋担任代理首席执行官 职

Group 1 - The company announced that its executive director, Su Weiguo, will suspend his role as CEO due to health reasons [1] - The board has appointed Zheng Zefeng, the company's executive director and CFO, as the acting CEO effective immediately [1] - Zheng will oversee the company's ongoing operations and management during the transition period to ensure continuity in leadership and decision-making [1]